99MTC-TILMANOCEPT SPECT IMAGING AS A POTENTIAL NON-INVASIVE METHOD TO QUANTIFY CD206+ TUMOR-ASSOCIATED M2-LIKE MACROPHAGES IN TRIPLE NEGATIVE BREAST CANCER. (October 2021)